期刊文献+

ntPCR-RFLP检测HBV阿德福韦耐药变异-rtA181V变异 被引量:3

Application of nest PCR-RFLP in the detection of adefovir dipivoxil resistance-associated mutation in hepatitis B virus
下载PDF
导出
摘要 目的:建立一种简便、快速、实用的乙型肝炎病毒(HBV)阿德福韦(ADV)耐药变异- rtA181V变异的快速检测方法.方法:根据GenBank收录的HBV基因全序设计巢式PCR引物,使野生株(rt181 A)PCR产物中含有Blp Ⅰ酶切位点(5’GCTNAGC3’),而变异株(rt181V)无此限制性酶切位点.选取4份应用ADV治疗1 a以上出现HBV DNA反跳的临床耐药慢性乙型肝炎患者血清,经PCR扩增、Blp Ⅰ酶切、30 g/L琼脂糖凝胶电泳,进行限制性片段长度多态性(RFLP)分析.并选择经该方法鉴定的野生株及变异株各一例进行 HBV RT区基因序列分析及对照质粒的构建.结果:自4份血清标本中检测到2例rtA181V变异.所建立的ntPCR—RFLP方法灵敏度高,可以检测到103 copies/L的HBV DNA;特异性强,其 RFLP分析结果与DNA测序结果一致.结论:应用ntPCR-RFLP方法检测rtA181V 变异具有灵敏、特异、简便的优点,适用于 ADV耐药变异的临床监测工作. AIM: To establish a simple, accurate and practical method for the detection of adefovir dipivoxil resistance-associated mutation (rtA181V mutation) in hepatitis B virus. METHODS: Four shares of serum were collected from patients who had been treated with adefovir dipivoxil for more than 1 year, and HBV DNA replication reoccurred. Two pairs of primers were designed to amplify the region of HBV reverse transcriptase codon 181(rt181) in order to introduce a BlpI restriction site upon PCR product of wild type (wt). After amplification, the PCR products were digested with BlpI and then subjected to electrophoresis. The patterns of rtA181V mutation were detected by restriction fragment length polymorphism (RFLP) analysis. RESULTS: Of the 4 patients, rtA181V mutation was detected in 2 cases by the above method. The established nest PCR-RFLP assay could detect HBV DNA at the level of 103 copies/L. The result of RFLP analysis was in accordance with that of DNA sequencing. CONCLUSION: The ntPCR-RFLP assay is a rapid, simple, specific and sensitive method for the detection of rtA181V mutation in HBV.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第7期714-717,共4页 World Chinese Journal of Digestology
基金 首都医学发展科研基金 No.2002-3046
关键词 阿德福韦 肝炎病毒 乙型 变异 ntPCR-RFLP 耐药变异 rtA181V变异 Adefovir dipivoxil Hepatitis B virus Mutation
  • 相关文献

参考文献13

  • 1Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL. Adefovir dipivoxil for the treatment of hepatitis Be antigen-negative chronic hepatitis B. N Engl J Med 2003; 348: 800-807.
  • 2Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL. Adefovir dipivoxil for the treatment of hepatitis Be antigen-positive chronic hepatitis B. N Engl J Med 2003; 348: 808-816.
  • 3Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve JP, Lama N, James C, Wulfsohn MS, Namini H, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. Hepatology 2003; 38: 1419-1427.
  • 4Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, Brosgart C, Colledge D, Edwards R, Ayres A, Bartholomeusz A, Locarnini S. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 2003; 125: 292-297.
  • 5Villeneuve JP, Durantel D, Durantel S, Westland C, Xiong S, Brosgart CL, Gibbs CS, Parvaz P, Werle B, Trepo C, Zoulim F. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. J Hepatol 2003; 39: 1085-1089.
  • 6闫杰,冯鑫,王磊,宋淑静,谢雯,欧蔚妮,李蕴铷.ntPCR-RFLP检测HBV阿德福韦耐药变异-rtN236T变异[J].世界华人消化杂志,2005,13(4):543-545. 被引量:9
  • 7闫杰,冯鑫,王磊,宋淑静,谢雯,李蕴铷.拉米夫定治疗中病毒核酸无应答患者体内乙型肝炎病毒逆转录酶基因变异分析[J].世界华人消化杂志,2005,13(1):130-132. 被引量:4
  • 8Fung SK, Andreone P, Han SH, Rajender Reddy K, Regev A, Keeffe EB, Hussain M, Cursaro C, Richtmyer P, Marrero JA, Lok AS. Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol 2005; 43: 937-943 .
  • 9茅益民,曾民德.抗乙型病毒性肝炎新药——阿德福韦酯[J].中华肝脏病杂志,2004,12(1):61-63. 被引量:266
  • 10封波,魏来,陈明,李秀华.包含YMDD基因序列的乙型肝炎病毒P区基因变异的研究[J].中华肝脏病杂志,2004,12(1):29-31. 被引量:17

二级参考文献62

共引文献339

同被引文献31

  • 1闫杰,冯鑫,王磊,宋淑静,谢雯,欧蔚妮,李蕴铷.ntPCR-RFLP检测HBV阿德福韦耐药变异-rtN236T变异[J].世界华人消化杂志,2005,13(4):543-545. 被引量:9
  • 2Yeon JE,Yoo W,Hong SP.阿德福韦双酯治疗拉米夫定耐药的慢性乙肝患者时出现的耐药问题[J].中国处方药,2006(3):23-23. 被引量:81
  • 3闫杰,谢雯,王磊,冯鑫,宋淑静,王晶波,刘顺爱,魏红山.应用巢式聚合酶链反应-限制性片段长度多态技术检测乙型肝炎病毒阿德福韦耐药变异-rtN236T变异[J].胃肠病学和肝病学杂志,2006,15(3):236-238. 被引量:2
  • 4Bartholomeusz A,Locarnini S,Ayres A,et al.Molecular modeling of hepatitis B virus polymerase and adefovir resistance identifies three clusters of mutations. Hepatology . 2004
  • 5Schildgen,O,Sirma,H,Funk,A.et al.Primary resistance of a novel hepatitis B vires variant to adefovir.. Hepatology . 2006
  • 6Colonno R,Rose R,Levine S,et al.Entecavir two year resistance update:no resistance observed in nucleoside naive patients and low frequency resistance emergence in lamivudine refractory patients. Hepatology . 2005
  • 7Heo J,,Cho M,Kim HH,et al.Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection. Journal of Korean Medical Science . 2004
  • 8Chayama K,Suzuki Y,Kobayashi M,et al.Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology . 1998
  • 9Stuyver L,Van Geyt C,De Gendt S,et al.Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. Journal of Clinical Microbiology . 2000
  • 10Whalley S A,Brown D,Teo C G,et al.Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using LightCycler. Journal of Clinical Microbiology . 2001

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部